Payer Spectrum Resource Center

This presentation is a companion piece to the Assessing Clinical Value of Oncology Treatments brief and provides payers with a concise overview of the complex and changing dynamics affecting cancer research, diagnosis, treatment, and care. This resource can engage staff members about specific oncology challenges at their organization and opportunities to improve care and outcomes.

This issue brief was developed to provide payers with insights into how the Affordable Care Act (ACA) of 2010 will impact oncology management in the coming years. It explores many provisions of the ACA that are likely to affect payers, government, oncologists, pharmaceutical manufacturers, and patients with cancer. This brief serves as a resource to support decision making in oncology management.

This presentation is a companion piece to the Impact of Healthcare Reform on Oncology brief and provides payers with insights into how the Affordable Care Act (ACA) of 2010 will impact oncology management in the coming years. The presentation can serve as a springboard for discussions about how the ACA will impact payers and may help shape oncology initiatives.

This brief will help payers focus on the emerging field of personalized medicine. It provides insights into the cost-effectiveness of molecular technologies and the link to health outcomes. It also examines regulatory policies, coding and reimbursement, and educational needs related to personalized medicine. This resource will help inform payers' decisions related to implementing personalized medicine to improve clinical outcomes.

This presentation is a companion piece to the Moving Toward Personalized Medicine brief and provides insights into the cost-effectiveness of molecular technologies and the link to health outcomes. It will help staff members better understand this emerging area. This presentation can also foster discussions about the value of personalized medicine for payers and what initiatives are being considered to implement it.

This report helps payers examine the impact of split-fill programs for oncology patients as a strategy to help reduce waste of unused cancer drugs. It also identifies potential associated cost increases and the unintended consequences for health plans. This concise resource can help inform benefit design considerations.

This brochure offers payers a snapshot of the incidence and costs associated with common and rare cancers, and reinforces opportunities for improving care, such as screening and early diagnosis. This resource serves as a national benchmark of costs related to common cancers and sheds light on the increased incidence of rare cancers to inform oncology management decisions.

This monograph features an in-depth analysis of the PharMetrics^® Integrated Database and literature review that will help payers understand Ph+ CML disease, current epidemiology and prognosis, current management strategies, and costs to payer organizations and society. The monograph highlights the medical and economic benefits of appropriate monitoring of patients with Ph+ CML.

This brief in the Payer Spectrum™ series will provide payers with an overview of BCR-ABL transcript monitoring in the management of patients with Philadelphia–chromosome positive chronic myeloid leukemia (Ph+ CML). It describes the sensitive real-time quantitative polymerase chain reaction (RQ-PCR) test used to detect BCR-ABL, the effort underway to standardize RQ-PCR testing and reporting methods, and the importance of BCR-ABL monitoring.